Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Francesco Negro

Showing results (281-290 of 334) with videos related to

Pageof 34
Sort By:
The Journal of Antimicrobial Chemotherapy|December 8, 2006
In vitro antiviral activity of SCH446211 (SCH6), a novel inhibitor of the hepatitis C virus NS3 serine proteaseRong Liu, Karim Abid, John Pichardo, et al.
Hepatology (Baltimore, Md.)|February 27, 2010
Systemic and intrahepatic interferon-gamma-inducible protein 10 kDa predicts the first-phase decline in hepatitis C virus RNA and overall viral response to therapy in chronic hepatitis CGalia Askarieh, Asa Alsiö, Paolo Pugnale, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|April 4, 2019
Very Low Hepatitis C Viral Loads in Treatment-naive Persons: Do They Compromise Hepatitis C Virus Antigen Testing?Barbara Bertisch, Matteo Brezzi, Francesco Negro, et al.
Journal of Hepatology|February 17, 2020
Real-world effectiveness and safety of glecaprevir/pibrentasvir for the treatment of patients with chronic HCV infection: A meta-analysisPietro Lampertico, Jose A Carrión, Michael Curry, et al.
Scientific Reports|August 23, 2016
Effect of Quercetin on Hepatitis C Virus Life Cycle: From Viral to Host TargetsÁngela Rojas, Jose A Del Campo, Sophie Clement, et al.
Journal of Hepatology|September 6, 2015
Dysregulation of distal cholesterol biosynthesis in association with relapse and advanced disease in CHC genotype 2 and 3 treated with sofosbuvir and ribavirinZobair M Younossi, Maria Stepanova, Michael Estep, et al.
Journal of Hepatology|May 14, 2013
Comparative genetic analyses point to HCP5 as susceptibility locus for HCV-associated hepatocellular carcinomaChristian M Lange, Stéphanie Bibert, Jean-François Dufour, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|December 25, 2019
Tolerogenic properties of liver macrophages in non-alcoholic steatohepatitisLorenzo A Orci, Mario Kreutzfeldt, Nicolas Goossens, et al.
Revue Medicale Suisse|January 14, 2021
Aude Nguyen, Klara Posfay-Barbe, Géraldine Blanchard-Rohner, et al.
Nature Communications|November 29, 2017
Hepatic protein tyrosine phosphatase receptor gamma links obesity-induced inflammation to insulin resistanceXavier Brenachot, Giorgio Ramadori, Rafael M Ioris, et al.
Pageof 34

Showing results (281-290 of 334) with videos related to

Sort By:
Pageof 34
The Journal of Antimicrobial Chemotherapy|December 8, 2006
In vitro antiviral activity of SCH446211 (SCH6), a novel inhibitor of the hepatitis C virus NS3 serine proteaseRong Liu, Karim Abid, John Pichardo, et al.
Hepatology (Baltimore, Md.)|February 27, 2010
Systemic and intrahepatic interferon-gamma-inducible protein 10 kDa predicts the first-phase decline in hepatitis C virus RNA and overall viral response to therapy in chronic hepatitis CGalia Askarieh, Asa Alsiö, Paolo Pugnale, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|April 4, 2019
Very Low Hepatitis C Viral Loads in Treatment-naive Persons: Do They Compromise Hepatitis C Virus Antigen Testing?Barbara Bertisch, Matteo Brezzi, Francesco Negro, et al.
Journal of Hepatology|February 17, 2020
Real-world effectiveness and safety of glecaprevir/pibrentasvir for the treatment of patients with chronic HCV infection: A meta-analysisPietro Lampertico, Jose A Carrión, Michael Curry, et al.
Scientific Reports|August 23, 2016
Effect of Quercetin on Hepatitis C Virus Life Cycle: From Viral to Host TargetsÁngela Rojas, Jose A Del Campo, Sophie Clement, et al.
Journal of Hepatology|September 6, 2015
Dysregulation of distal cholesterol biosynthesis in association with relapse and advanced disease in CHC genotype 2 and 3 treated with sofosbuvir and ribavirinZobair M Younossi, Maria Stepanova, Michael Estep, et al.
Journal of Hepatology|May 14, 2013
Comparative genetic analyses point to HCP5 as susceptibility locus for HCV-associated hepatocellular carcinomaChristian M Lange, Stéphanie Bibert, Jean-François Dufour, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|December 25, 2019
Tolerogenic properties of liver macrophages in non-alcoholic steatohepatitisLorenzo A Orci, Mario Kreutzfeldt, Nicolas Goossens, et al.
Revue Medicale Suisse|January 14, 2021
Aude Nguyen, Klara Posfay-Barbe, Géraldine Blanchard-Rohner, et al.
Nature Communications|November 29, 2017
Hepatic protein tyrosine phosphatase receptor gamma links obesity-induced inflammation to insulin resistanceXavier Brenachot, Giorgio Ramadori, Rafael M Ioris, et al.
Pageof 34